Irenic Acquisition Corp Unit

IACQU

Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Street research is expected for one company, and lock-up periods will be expiring for six companies.

NEW YORK--(BUSINESS WIRE)--Irenic Acquisition Corp. (the “Company”) announced today that the underwriters of its initial public offering exercised their over-allotment option in part to purchase an additional 3,253,188 units at the public offering price of $10.00 per unit, bringing the total units sold in the initial public offering to 25,253,188 units, or an aggregate amount of $252,531,880 raised in the offering. The over-allotment option closed today on May 1, 2026. Each unit consists of one.